Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grupo Leisa is a Mexican pharmaceutical group dedicated to the manufacturing, distribution, and commercialization of health products and medicines. The company operates through several divisions, including Laboratorios Leisa, which focuses on the production of generic and specialized pharmaceutical forms such as injectables and oral solids. They serve both the public and private healthcare sectors in Mexico, providing a wide range of therapeutic solutions including oncology, infectious diseases, and critical care. Grupo Leisa also provides logistics and distribution services for medical supplies and equipment to hospitals and clinics. The company is a significant supplier to major Mexican government health institutions like IMSS and ISSSTE.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grupo Leisa.